Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (4.075.132 €): Glyco-Nanopartikel für Anwendungen in der Advance Nanomedizin Hor 01.10.2018 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Glyco-Nanopartikel für Anwendungen in der Advance Nanomedizin
The advance of nanomedicine requires the development of novel materials with tailored properties, controlled circulation, optimal targeting and therapeutic efficacy after administration. Nanomaterials engineered with glycans offer multiple possibilities for nanomedicine as these biomolecules when arranged on a nanomaterial surface display strong binding to specific receptors while at the same time the glyco coating can restrict unspecific interactions with proteins, helping to avoid the mononuclear phagocyte system and improved biocompatibility in vivo. The NanoCarb Network will develop novel and well-characterised nanomaterials with synthetic and native N-glycans that will be used for therapeutics and guide development of new drug delivery applications. The project will train early stage researchers at the interface of nanotechnology and glycosciences, with the overall goal of achieving a new generation of professionals in nanomedicine for a prospective career in both academia and industry. To achieve this goal a multidisciplinary consortium has been created including universities, research centres and SMEs with broad expertise ranging from nanotechnology, carbohydrate chemistry, glycoprofiling and in vitro – in vivo screening specialists. An ambitious training plan will be implemented including courses, outreach activities, participation in seminar, and workshops for the development of scientific and transferable skills.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Accelopment Schweiz AG | ? |
| Asociacion Centro de Investigacion CRL en Biomateriales- Cic biomaGUNE | 501.810 € |
| Consiglio Nazionale Delle Ricerche | 170.701 € |
| Istituto Di Ricerche Farmacologiche Mario Negri | 522.999 € |
| Ludger Ltd. | 303.173 € |
| Midatech Ltd. | 0,00 € |
| Midatech Pharma Espana SL | 174.240 € |
| Royal College of Surgeons in Ireland | 1.278.045 € |
| Universita Degli Studi Di Milano | 261.500 € |
| University of Warwick | 606.345 € |
| Vlaamse Instelling Voor Technologisch Onderzoek N.V. | 256.320 € |
Quelle: https://cordis.europa.eu/project/id/814236
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: accelopment Schweiz AG, Zürich, Schweiz.